| Financial Year |
March 31 2023 |
| Monetary Funds |
30,357,638.96 |
| Held-for-trading Financial Assets |
477,245,298.81 |
| Notes Receivable |
-- |
| Accounts Receivable |
66,752,197.58 |
| Advances to Suppliers |
863,561.64 |
| Other Receivables |
834,944.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
126,842,744.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,338,327.89 |
| Total Current Assets |
706,234,713.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,222,273.20 |
| Investment Properties |
-- |
| Fixed Assetes |
276,181,536.26 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
92,847,501.29 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,912,262.57 |
| Deferred Income Tax Assets |
9,895,103.47 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
391,058,676.79 |
| Total Assets |
1,097,293,390.36 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
5,550,579.23 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,795,993.52 |
| Taxes Payable |
2,097,764.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
912,894.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
162,017.65 |
| Sub-Total of Current Liabilities |
18,558,185.08 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
274,064.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
42,254,995.97 |
| Total Liabilities |
60,813,181.05 |
| Paid-In Capital(Or Share Stock) |
320,016,000.00 |
| Capital Surplus |
414,340,084.89 |
| Surplus Reserve |
39,571,201.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
262,552,922.43 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,036,480,209.31 |
| Owner's Equity（Stockholder's Equity） |
1,036,480,209.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,097,293,390.36 |
